Drugs & Targets Medicinal product designation for TB-403 for medulloblastoma January 20, 2017Vol.43 No.03
Drugs & TargetsFree Scripps to collaborate with Pfizer to advance DNA-encoded library technology January 13, 2017Vol.43 No.02
Drugs & TargetsFree AbbVie announces four new global research collaborations January 13, 2017Vol.43 No.02
Drugs & TargetsFree Lilly and Merck expand immuno-oncology collaboration January 13, 2017Vol.43 No.02
Drugs & TargetsFree Amgen and Immatics collaborate to develop cancer immunotherapies January 13, 2017Vol.43 No.02
Drugs & TargetsFree Philips and Illumina to co-develop integrated genomics solutions for oncology January 13, 2017Vol.43 No.02
Drugs & TargetsFree Tecentriq receives priority review for treatment of urothelial carcinoma January 13, 2017Vol.43 No.02
Drugs & TargetsFree EMD Serono and MD Anderson enter three-year collaboration January 13, 2017Vol.43 No.02
Drugs & TargetsFree MD Anderson and Deerfield Management create company to inhibit autophagy January 13, 2017Vol.43 No.02
